Full Issue

Individual Articles - Jan/Feb 2020 - Volume 24, Number 1

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2020 Pg. 4	PreScription: One Size Does Not Fit All! Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 7-12	Primary Engineering Controls in Pharmaceutical Compounding, Part 2: Biosafety Cabinets Author(s): Mulder Kyle
Jan/Feb 2020 Pg. 14-19	How to Qualify Container Closure Systems for Intended Use, Part 2: Choosing the Right Components for Container Closure Systems Author(s): Vaughn Stacey R, Radwick Allison
Jan/Feb 2020 Pg. 21-27	Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk Author(s): Cabaleiro Joe
Jan/Feb 2020 Pg. 28-29	New and Improved! Author(s): Brunner Scott
Jan/Feb 2020 Pg. 30-36	Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Author(s): Dillon L R
Jan/Feb 2020 Pg. 38-43	Basics: Excipients Used in Nonsterile Compounding, Part 4: Antioxidants and Chelating Agents Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 44-50	Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 52	Calculations Author(s): Stockton Shelly J
Jan/Feb 2020 Pg. 54	Amiodarone Hydrochloride 5 mg/mL in SyrSpend SF pH4 Cherry Flavored Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 55	Glutamine 250 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 56	Glycopyrrolate 0.2 mg/mL in Methylcellulose 1% and Syrup Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 57	Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 58	Isoniazid 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 59	LCD 5%, Salicylic Acid 6% in Clobetasol Propionate 0.05% Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 60	Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 61	Potassium Chloride 1 mmol/mL in Ora-Sweet SF Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 62	Progesterone 100-mg, Melatonin 1-mg, and L-Theanine 200-mg Slow-Release Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 63	Venlafaxine 15 mg/mL in Syrup Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 64-68	Long-term Physicochemical Stability of Concentrated Solutions of Isosorbide Dinitrate in Polypropylene Syringes for Administration in the Intensive Care Unit Author(s): Lardinois Benjamin, Dimitriou Alexandre, Delcave Charlotte, Soumoy Laura, Jamart Jacques, Bihin Benoît, Hecq Jean-Daniel, Galanti Laurence M
Jan/Feb 2020 Pg. 69-76	Clinical Efficacy of a Topical Compounded Formulation in Male Androgenetic Alopecia: Minoxidil 10%, Finasteride 0.1%, Biotin 0.2%, and Caffeine Citrate 0.05% Hydroalcoholic Solution Author(s): Marotta James C, Patel Gopesh, Carvalho Maria, Blakeney Samantha
Jan/Feb 2020 Pg. 77-82	Stability of Metronidazole Free-base Oral Suspensions Formulated with United States Pharmacopeia-grade Metronidazole Powder and Commercial Metronidazole Tablets Author(s): Jarouche Marian, Ibrahim Martha, Pearson Jarryd, Low Mitchell, Rowe James
Jan/Feb 2020 Pg. 83-85	Compatibility of Melphalan in Iodinated Contrast Media Author(s): Shi Zhanquan, Abruzzo Todd, Wanasathop Apipa, Li S Kevin
Jan/Feb 2020 Pg. 86-87 View Sample	Errata - How to Qualify Container Closure Systems for Intended Use, Part 1 - IJPC 23(6) 454-461 Author(s):